Commonly prescribed GLP-1 receptor agonists include semaglutide (sold under brand names like Wegovy and Ozempic) and tirzepatide (marketed as Mounjaro)
And when you take it again, youre going to have that side effect again because there hasnt been a steady amount of the medication in your system. Additionally, access and availability have been an issue
MeAgain helps because your side-effect logs live beside the things that often matter during a GLP-1 routine: dose day, shot or pill timing, food tolerance, protein, fiber, water, bowel changes, weight trend, and progress
E88.81 Metabolic syndrome E34.9 Endocrine disorder, unspecified Identifying and coding these conditions can aid in developing comprehensive weight management plans tailored to individual patient needs
NICE guidance (NG28) recommends GLP-1 therapy for type 2 diabetes when metformin and other oral medications haven't achieved adequate control, typically in combination with insulin or as an alternative to insulin in specific circumstances
Join 50,000+ readers
